Found 32 results
Author Title [ Type(Desc)] Year
Filters: Author is Carter, S  [Clear All Filters]
Conference Paper
L. A. Baxter-Lowe, Kim, Y., Carter, S., Fernandez-Vina, M. A., Wagner, E., Jensen, L., Fraser, J., Kernan, N., and Kurtzberg, J., Ability of Minority Patients to Find Donors from an Ethnically Diverse Cord Blood Bank, in Annual Meeting of the American Society for Histocompatibility and Immunogenetics, Miami, FL, 2002, vol. 100, p. 640a-641a.
C. Keever-Taylor, Devine, S., Soiffer, R., Carter, S., Pasquini, M., Hari, P., Stein, A., Lazarus, H., Linker, C., Goldstein, S., and O’Reilly, R., Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract)., in 16th Annual ISCT (International Society for Cellular Therapy) Meeting, Philadelphia, 2010.
C. Gurgol, Foley, A., Belt, P., Denzen, E., Duffy, S., Gallagher, C., Grodman, C., Horowitz, M., Confer, D., and Carter, S., Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster)., in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
A. Foley, Horowitz, M., Confer, D., and Carter, S., Development of an Accrual Assessment Tool for BMT CTN Transplant Trials: A Proactive Approach, in NCI ASCO Cancer Trials Accrual Symposium Poster Session, Bethesda, MD, 2010.
M. Pasquini, Foley, A., Carter, S., Confer, D., Horowitz, M., Gurgol, C., Giralt, S., Schilsky, R., and McCarthy, P., Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster)., in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
S. M. Devine, Owza, K., Blum, W., DeAngelo, D., Stone, R. M., Wingard, J., Champlin, R., Chen, Y., Vij, R., Slack, J., Brown, R., Soiffer, R., Larson, R., Shea, T., Hars, V., Bennett, E., Spangle, S., Giralt, S., Carter, S., Horowitz, M., Linker, C., and Alyea, E. P., A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
P. Martin, Carter, S., Kernan, N. A., Sahdev, I., Wall, D., Pietryga, D., Wagner, J. E., and Kurtzberg, J., Results of the Cord Blood Transplantation Study (COBLT): Clinical Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Inborn Errors of Metabolism, in 2005 ASBMT Tandem BMT Meetings, Keystone, CO, 2005.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W., Pasquini, M., MacMillan, M., Wingard, J., Waller, E., Grupp, S., McCarthy, P., Wu, J., Hu, Z., Carter, S., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
Journal Article
G. Cohen, Carter, S., Weinberg, K., Masinsin, B., Guinan, E., Kurtzberg, J., Wagner, J., Kernan, N., and Parkman, R., Antigen-Specific T-Lymphocyte Function After Cord Blood Transplantation, Biol Blood Marrow Transplant, vol. 12, pp. 1335-1342, 2006.
D. Weisdorf, Carter, S., Confer, D., Ferrara, J., and Horowitz, M., Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions, Biol Blood Marrow Transplant, vol. 13, no. 3, pp. 257-262, 2007.
V. T. Ho, Cutler, C., Carter, S., Martin, P., Adams, R., Horowitz, M., Ferrara, J., Soiffer, R., and Giralt, S., Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation, Biol Blood Marrow Transplant, vol. 11, pp. 571-575, 2005.
C. A. Keever-Taylor, Devine, S. M., Soiffer, R. J., Mendizabal, A., Carter, S., Pasquini, M. C., Hari, P. N., Stein, A., Lazarus, H. M., Linker, C., Goldstein, S. C., Stadtmauer, E. A., and O'Reilly, R. J., Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303, Biol Blood Marrow Transplant, vol. 18, pp. 690-697, 2012.
M. Pasquini, Devine, S., Mendizabal, A., Baden, L. R., Wingard, J., Lazarus, H. M., Appelbaum, F. R., Keever-Taylor, C. A., Horowitz, M. M., Carter, S., O'Reilly, R. J., and Soiffer, R., Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy as Graft-Versus-Host Disease Prophylaxis for Patients with Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transpl, J Clin Oncol, vol. 30, pp. 3194-3201, 2012.
K. M. Page, Zhang, L., Mendizabal, A., Wease, S., Carter, S., Shoulars, K., Gentry, T., Balber, A. E., and Kurtzberg, J., The Cord Blood Apgar: A Novel Scoring System to Optimize Selection of Banked Cord Blood Grafts for Transplantation (CME)., Transfusion, vol. 52, pp. 272-283, 2012.
M. Cairo, Cohen, G., Wagner, E., Fraser, J., Jensen, L., Carter, S., Kernan, N., and Kurtzberg, J., Cord Blood (CB) Hematopoietic Progenitor Cell (HPC) Characterization and Correlation with Ethnicity: A Report From The COBLT Study, 2004.
M. Cairo, Wagner, E., Cohen, G., Fraser, J., Jensen, L., Carter, S., van de Ven, C., Kernan, N. A., and Kurtzberg, J., Cord Blood Log CD34+ and CD34+ Subsets (CD38-, CD61+, CD90+) are Significantly Correlated to Log Total CFU, CFU-GEMM, CFU-GM and BFU-E: A Report From The COBLT/NHLBI Program, 2004.
G. de Lissovoy, Hurd, D., Carter, S., Beatty, P., Ewell, M., Henslee-Downey, J., Kernan, N., Yanovich, S., and Weisdorf, B., Economic Analysis of Unrelated Allogeneic Bone Marrow Transplantation: Results From The Randomized Clinical Trial of T-Cell Depletion vs Unmanipulated Grafts for the Prevention of Graft-Versus-Host Disease, Bone Marrow Transplant, vol. 36, pp. 539-546, 2005.
E. M. Altmaier, Ewell, M., McQuellon, R., Geller, N., Carter, S., Henslee-Downey, J., Davies, S., Papadopoulos, E., Yanovich, S., and Gingrich, R., The Effect of Unrelated Donor Marrow Transplantation on Health-Related Qualify of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-cell Depletion Trial), Biol Blood Marrow Transplant, vol. 12, pp. 648-655, 2006.
A. Alousi, Weisdorf, D., Logan, B., Bolanos-Meade, J., Carter, S., DiFronzo, N., Pasquini, M., Goldstein, S., Ho, V., Hayes-Lattin, B., Wingard, J., Horowitz, M., and Levine, J., Etanercept, Mycophenolate, Denileukin, or Pentostatin Plus Corticosteroids for Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial from the Blood and Marrow Transplant Clinical Trials Network, Blood, vol. 114, pp. 511-517, 2009.
N. L. Reinsmoen, Matas, A. J., Donaldson, L., and Carter, S., Impact of Transfusions and Acute Rejection on Post-Transplant Donor Antigen-Specific Responses in Two Study Populations, Transplantation, vol. 67, pp. 697-702, 1999.
J. E. Wagner Jr., Eapen, M., Carter, S., Wang, Y., Schultz, K., Wall, D., Bunin, N., Delaney, C., Haut, P., Margolis, D., Peres, E., Verneris, M., Walters, M., Horowitz, M., and Kurtzberg, J., One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers, N Engl J Med, vol. 371, pp. 1685-1694, 2014.
K. M. Page, Mendizabal, A., Betz-Stablein, B., Wease, S., Shoulars, K., Gentry, T., Prasad, V., Sun, J., Carter, S., Balber, A., and Kurtzberg, J., Optimizing Donor Selection for Public Cord Blood Banking: Influence of Maternal, Infant, and Collection Characteristics On Cord Blood Unit Quality, Transfusion, vol. 54, pp. 340-352, 2014.
C. Anasetti, Logan, B., Lee, S., Waller, E., Weisdorf, D., Wingard, J., Cutler, C., Westervelt, P., Woolfrey, A., Couban, S., Ehringer, G., Johnston, L., Maziarz, R., Pulsipher, M. A., Porter, D., Mineishi, S., McCarty, J., Khan, S., Anderlini, P., Bensinger, W., Leitman, S., Rowley, S., Bredeson, C., Carter, S., Horowitz, M., and Confer, D., Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors, N Engl J Med, vol. 367, no. 16, pp. 1487-1496, 2012.
J. M. Vose, Carter, S., Burns, L. J., Ayala, E., Press, O. W., Moskowitz, C. H., Stadtmauer, E. A., Mineshi, S., Ambinder, R., Fenske, T., Horowitz, M., Fisher, R., and Tomblyn, M., Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT C, J Clin Oncol, vol. 31, pp. 1662-1668, 2013.
D. J. Weisdorf, Hurd, D., Carter, S., Howe, C., Jensen, L. A., Wagner, J., Stablein, D., Thompson, J., and Kernan, N. A., Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review, Biol Blood Marrow Transplant, vol. 9, pp. 512-8, 2003.